PUMA SE (BIT:1PUM)

Market Cap	2.53B
Revenue (ttm)	8.62B
Net Income (ttm)	-94.30M
Shares Out	n/a
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	0.61 (3.36%)
Ex-Dividend Date	May 22, 2025

Volume	1,055
Average Volume	12,039
Open	17.49
Previous Close	17.94
Day's Range	17.33 - 17.49
52-Week Range	17.34 - 47.60
Beta	n/a
RSI	28.66
Earnings Date	Jul 31, 2025

About Ligand Pharmaceuticals

PUMA SE, together with its subsidiaries, engages in the development and sale of sports and sports lifestyle products in Germany, rest of Europe, the United States, North America, and internationally. The company offers sports lifestyle products for football, handball, rugby, cricket, volleyball, track and field, motorsports, golf, and basketball. It also issues licenses to independent partners to design, develop, manufacture, and sell glasses, safety shoes, workwear, and gaming accessories. It sells its products under the PUMA and Cobra Golf br...

• Industry: Rubber and Plastics Footwear
• Founded: 1919
• Employees: 22,214
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PUM

Financial Performance

In 2024, PUMA SE's revenue was 8.82 billion, an increase of 2.51% compared to the previous year's 8.60 billion. Earnings were 281.60 million, a decrease of -7.64%.